ITFEX
Price
$10.82
Change
-$0.12 (-1.10%)
Updated
Jul 23 closing price
Net Assets
174.42M
TRIGX
Price
$26.79
Change
+$0.07 (+0.26%)
Updated
Jul 24 closing price
Net Assets
16.57B
Interact to see
Advertisement

ITFEX vs TRIGX

ITFEX vs TRIGX Comparison Chart in %
View a ticker or compare two or three
VS
ITFEX vs. TRIGX commentary
Jul 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITFEX is a Buy and TRIGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRIGX has more cash in the bank: 16.6B vs. ITFEX (174M). ITFEX pays higher dividends than TRIGX: ITFEX (5.97) vs TRIGX (2.38). ITFEX was incepted earlier than TRIGX: ITFEX (17 years) vs TRIGX (28 years). ITFEX (1.16) is less costly to investors than TRIGX (0.81). ITFEX is a more actively managed with annual turnover of: 82.00 vs. TRIGX (15.00). ITFEX has a lower initial minimum investment than TRIGX: ITFEX (0) vs TRIGX (2500). TRIGX annual gain was more profitable for investors over the last year : 25.27 vs. ITFEX (-12.03). TRIGX return over 5 years is better than : 94.38 vs. ITFEX (27.04).
ITFEXTRIGXITFEX / TRIGX
Total Expense Ratio1.160.81143%
Annual Report Gross Expense Ratio1.160.81143%
Fund Existence17 years28 years-
Gain YTD-16.47112.658-130%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets174M16.6B1%
Annual Yield % from dividends5.972.38251%
Returns for 1 year-12.0325.27-48%
Returns for 3 years24.2180.8430%
Returns for 5 years27.0494.3829%
Returns for 10 years37.34154.7224%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MECZX57.440.12
+0.21%
AMG GW&K International Small Cap Z
GSIFX33.830.05
+0.15%
Goldman Sachs International Eq ESG A
JGRQX20.88-0.22
-1.04%
JPMorgan Small Cap Growth R3
AMGAX18.44-0.24
-1.28%
Alger Mid Cap Growth A
JHUKX50.34-1.11
-2.16%
JPMorgan Emerging Markets Equity R4